ACLX Stock Summary and Trading Ideas (Arcellx | NASDAQ:ACLX)

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Arcellx trades on the NASDAQ stock market under the symbol ACLX.

As of May 8, 2024, ACLX stock price declined to $52.25 with 351,479 million shares trading.

ACLX has a beta of 1.98, meaning it tends to be more sensitive to market movements. ACLX has a correlation of 0.19 to the broad based SPY ETF.

ACLX has a market cap of $2.78 billion. This is considered a Mid Cap stock.

The top ETF exchange traded funds that ACLX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

ACLX has underperformed the market in the last year with a price return of +19.9% while the SPY ETF gained +27.0%. ACLX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.2% and -4.0%, respectively, while the SPY returned +4.2% and +2.3%, respectively.

ACLX support price is $50.63 and resistance is $54.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACLX stock will trade within this expected range on the day.